De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis

BACKGROUND: The role of adjuvant chemotherapy in gastric neuroendocrine neoplasms (GNEC) has not been well clarified yet. The study was designed to investigate the potential effect of adjuvant chemotherapy in stage I–II GNEC patients and construct a predictive nomogram. METHOD: Stage I–II GNEC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Danwei, Xie, Yangyang, Li, Xiaowen, Ni, Zhongkai, Shi, Jinbo, Huang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163728/
https://www.ncbi.nlm.nih.gov/pubmed/37149679
http://dx.doi.org/10.1186/s12957-023-03029-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163728/
https://www.ncbi.nlm.nih.gov/pubmed/37149679
http://dx.doi.org/10.1186/s12957-023-03029-2

Ejemplares similares